Related Experiment Video
Updated: Mar 8, 2026

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas
Marion Classe1, Gabriel G Malouf2, Xiaoping Su3
1Département de Pathologie, Hôpital Lariboisière, Assistance Publique Hôpitaux de Paris, Paris, France.
Aims:
Translocation renal cell carcinoma (tRCC) is a rare subtype of kidney tumour characterized by translocations involving the transcription factor TFE3 or TFEB. tRCC was introduced into the World Health Organization classification in 2004, but much is still unknown about the natural history, clinicopathological features and outcomes of the disease. The aim of this study was to describe the landscape of fusion transcript in a large single-institution series of fluorescence in-situ hybridization (FISH)-confirmed tRCCs and then to compare it to morphological and clinical data.
Methods And Results:
Paired-end RNA sequencing was performed within a prospective database of the Department of Pathology, Centre Hospitalier Régional Universitaire (Lille, France). The diagnosis of tRCC was confirmed by FISH. Among a total of 1130 identified renal cell carcinomas, 21 cases (1.9%) showed rearrangement of the TFE3 (n = 20) or (TFEB) (n = 1) gene. Median patient age was 31 years (range = 15-47), and the female-to-male ratio was 6:1. Five different TFE3 fusion transcripts were identified; the most frequent TFE3 partners were PRCC (n = 4) and SFPQ (n = 4). The other partners involved were ASPCR1 (n = 1) and MED15 (n = 1) genes as well as a novel TFE3 partner, GRIPAP1.
Conclusions:
We identified a new fusion partner, GRIPAP1. The prognostic role of transcript type could not be determined because our number of cases was too small. Four patients (19%) died of the disease, all of which presented with a lymph node involvement at diagnosis. We confirm that tRCC can be an aggressive tumour, especially those of advanced clinical stage.
Insights
Translocation renal cell carcinoma (tRCC) is a rare kidney cancer. This study identified a new fusion partner, GRIPAP1, in tRCC and confirmed its aggressive nature, particularly in advanced stages.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Translocation renal cell carcinoma (tRCC) is a rare kidney tumor subtype characterized by TFE3 or TFEB gene translocations.
- Despite its classification in 2004, much remains unknown about tRCC's natural history, clinicopathological features, and outcomes.
Purpose of the Study:
- To characterize the landscape of fusion transcripts in a large series of fluorescence in-situ hybridization (FISH)-confirmed tRCC cases.
- To correlate fusion transcript data with morphological and clinical information.
Main Methods:
- Paired-end RNA sequencing was conducted on a prospective database.
- Diagnosis of tRCC was confirmed using FISH.
- Analysis included 21 tRCC cases out of 1130 identified renal cell carcinomas.
Main Results:
- The study identified TFE3 gene rearrangements in 20 cases and TFEB in 1 case.
- Five distinct TFE3 fusion transcripts were found, with PRCC and SFPQ being the most common partners.
- A novel TFE3 fusion partner, GRIPAP1, was identified.
Conclusions:
- The study identified GRIPAP1 as a new fusion partner in tRCC.
- While the prognostic role of specific transcript types requires further investigation due to small sample size, tRCC can be aggressive.
- A significant proportion of patients (19%) died from the disease, often presenting with lymph node involvement.
More Related Videos
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
Related Concept Videos
Non-LTR Retrotransposons
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
lncRNA - Long Non-coding RNAs
Mechanisms of Retrovirus-induced Cancers
Abnormal Proliferation